Current Status of Treatment for Chinese Patients With ESR1-mutated HR+/HER2-advanced Breast Cancer
Clinical trial NCT06548919 · RECRUITING
Trial details
- NCT number
- NCT06548919
- Sponsor
- SciClone Pharmaceuticals
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-08-08
- Primary completion
- 2026-12-31
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.